Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver

Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver ID - 450664 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450664/all/Hepatic_artery_adjuvant_chemotherapy_for_patients_having_resection_or_ablation_of_colorectal_cancer_metastatic_to_the_liver PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -